| 摘要 |
PROBLEM TO BE SOLVED: To provide a new Th1 inducing agent having high safety, free from the problems of side actions, etc., and enabling the regulation of cytokine produced by helper T cell, based on the presumption attained by the recent advance in the immunological research that the balance of Th1 and Th2 has grave action on the onset and development of diseases, and to solve the recent problems of the increasing tendency of the promotion of Th2 from the living environment and, for example, the onset of cancer, immunodeficiency, asthma, dermatitis, allergic diseases, nephritis, infectious diseases, etc., caused by the function promotion of Th2. SOLUTION: The problems can be solved by finely pulverizing an immunizing antigen substance to a size smaller than 1μm, and applying a reagglomeration preventing treatment to the fine particles. COPYRIGHT: (C)2008,JPO&INPIT
|
